Mikhail A. Zhukovsky and Po-Hsien Lee contributed equally to this work.
Article
Putative cholesterol-binding sites in human immunodeficiency virus (HIV) coreceptors CXCR4 and CCR5
Article first published online: 24 DEC 2012
DOI: 10.1002/prot.24211
Copyright © 2012 Wiley Periodicals, Inc.
Issue

Proteins: Structure, Function, and Bioinformatics
Volume 81, Issue 4, pages 555–567, April 2013
Additional Information
How to Cite
Zhukovsky, M. A., Lee, P.-H., Ott, A. and Helms, V. (2013), Putative cholesterol-binding sites in human immunodeficiency virus (HIV) coreceptors CXCR4 and CCR5. Proteins, 81: 555–567. doi: 10.1002/prot.24211
- †
Mikhail A. Zhukovsky and Po-Hsien Lee contributed equally to this work.
Publication History
- Issue published online: 8 MAR 2013
- Article first published online: 24 DEC 2012
- Accepted manuscript online: 15 NOV 2012 01:58AM EST
- Manuscript Accepted: 11 OCT 2012
- Manuscript Revised: 31 AUG 2012
- Manuscript Received: 9 MAY 2012
Keywords:
- aromatic stacking interactions;
- chemokine receptor;
- conformational stability;
- CRAC motif;
- drug target;
- G protein-coupled receptor;
- membrane protein;
- molecular docking;
- nonannular binding site;
- sequence alignment
Abstract
Using molecular docking, we identified a cholesterol-binding site in the groove between transmembrane helices 1 and 7 near the inner membrane-water interface of the G protein-coupled receptor CXCR4, a coreceptor for HIV entry into cells. In this docking pose, the amino group of lysine K67 establishes a hydrogen bond with the hydroxyl group of cholesterol, whereas tyrosine Y302 stacks with cholesterol by its aromatic side chain, and a number of residues form hydrophobic contacts with cholesterol. Sequence alignment showed that a similar putative cholesterol-binding site is also present in CCR5, another HIV coreceptor. We suggest that the interaction of cholesterol with these putative cholesterol-binding sites in CXCR4 and CCR5 is responsible for the presence of these receptors in lipid rafts, for the effect of cholesterol on their conformational stability and function, and for the role that cell cholesterol plays in the cell entry of HIV strains that use these membrane proteins as coreceptors. We propose that mutations of residues that are involved in cholesterol binding will make CXCR4 and CCR5 insensitive to membrane cholesterol content. Cholesterol-binding sites in HIV coreceptors are potential targets for steroid drugs that bind to CXCR4 and CCR5 with higher binding affinity than cholesterol, but do not stabilize the native conformation of these proteins. Proteins 2013. © 2012 Wiley Periodicals, Inc.

1097-0134/asset/PROT_centre.gif?v=1&s=77b56b1f2cdaba74cb3bb149bd9b029cd8803cdb)